Synthesis of Spiranic and Tertiary α-Alkoxy-γ-keto Acid Derivatives
FULL PAPER
25%) as a colorless oil. [α]D = +44.2 (c = 0.8, CHCl3). H NMR
1
(300 MHz, CDCl3, 25 °C): δ = 7.68 (d, J = 3.2 Hz, 1 H), 7.25 (d,
J = 8.8 Hz, 1 H), 7.19 (d, J = 3.2 Hz, 1 H), 6.40 (m, 2 H), 5.78
(dd, J = 22.4, 10.7 Hz, 1 H), 5.19 (d, J = 7.3 Hz, 1 H), 4.91 (m, 2
H), 4.50 (d, J = 7.3 Hz, 1 H), 3.71 and 3.72 (s, each 3 H), 3.69 (s,
3 H), 1.97 (br. s, 1 H), 0.84 and 0.98 (s, each 3 H) ppm. 13C NMR
(75 MHz, CDCl3, 25 °C): δ = 175.5, 165.3, 156.9, 154.7, 143.0,
141.8, 126.5, 121.3, 119.2, 115.1, 104.0, 100.1, 99.5, 72.0, 66.2, 58.2,
56.5, 55.5, 42.1, 23.6, 21.3 ppm. IR (CHCl ): ν = 1743 cm–1. MS
˜
3
(ES): m/z (%) = 419 (100) [M + H]+, 418 (17) [M]+. C21H26N2O5S
(418.2): calcd. C 60.27, H 6.26, N 6.69; found C 60.39, H 6.21, N
6.63. The more polar fraction contained quaternary α-alkoxy-γ-
keto carboxamide (–)-9b (47 mg, 62%) as a pale yellow oil. [α]D
=
1
–71.0 (c = 0.6, CHCl3). H NMR (300 MHz, CDCl3, 25 °C): δ =
8.90 (br. s, 1 H), 8.25 (d, J = 8.5 Hz, 1 H), 8.00 (d, J = 3.2 Hz, 1
H), 7.66 (d, J = 3.2 Hz, 1 H), 6.47 (m, 2 H), 6.18 (dd, J = 17.5,
10.7 Hz, 1 H), 5.10 (m, 2 H), 3.80 and 3.89 (s, each 3 H), 3.73 and
4.13 (d, J = 19.0 Hz, each 1 H), 3.48 (s, 3 H), 1.06 (s, 6 H) ppm.
13C NMR (75 MHz, CDCl3): δ = 190.8, 169.5, 167.1, 156.3, 144.5,
144.0, 126.4, 121.0, 120.5, 113.3, 103.7, 98.7, 85.6, 55.8, 55.7, 54.9,
Scheme 4. Mechanistic explanation for the N1–C4 β-lactam bond
breakage of 3-substituted 3-alkoxy-β-lactam aldehydes 2 under
TMST/carbonyl addition conditions.
Conclusions
45.0, 38.1, 23.0, 22.2 ppm. IR (CHCl ): ν = 1742, 1726 cm–1. MS
˜
3
(EI): m/z (%) = 419 (8) [M + H]+, 418 (30) [M]+, 153 (100).
C21H26N2O5S (418.2): calcd. C 60.27, H 6.26, N 6.69; found C
60.40, H 6.22, N 6.73.
Spiranic as well as 3-substituted 3-alkoxy-β-lactam alde-
hydes, which were obtained from enantiopure azetidine-2,3-
diones, gave preferentially the N1–C4 β-lactam bond cleav-
age product rather than the carbonyl addition product by
reaction with 2-(trimethylsilyl)thiazole. The resulting op-
tically active spiranic and tertiary α-alkoxy-γ-keto acid de-
rivatives, which can be considered both as conformationally
constrained aldols as well as Passerini-type products, can-
not be easily achieved by alternative protocols.
Spiranic α-Alkoxy-γ-keto Carboxamide (–)-9c and β-Lactam (+)-
10c: From 4-oxoazetidine-2-carbaldehyde (+)-2c (70 mg,
0.25 mmol). Chromatography (EtOAc/hexanes, 2:3) gave two frac-
tions. The less polar fraction contained β-lactam (+)-10c (13 mg,
1
12%) as a colorless oil. [α]D = +28.0 (c = 0.8, CHCl3). H NMR
(300 MHz, CDCl3, 25 °C): δ = 7.84 (d, J = 3.3 Hz, 1 H), 7.56 (m,
3 H), 6.77 (d, J = 8.9 Hz, 2 H), 5.83 (s, 2 H), 5.50 (d, J = 6.5 Hz,
each 1 H), 4.57 (d, J = 6.5 Hz, each 1 H), 4.79 and 4.34 (d, J =
16.5 Hz, each 1 H), 3.80 (s, 3 H), 2.63 and 2.36 (d, J = 17.5 Hz,
each 1 H), –0.01 (s, 9 H) ppm. 13C NMR (75 MHz, CDCl3, 25 °C):
δ = 172.3, 165.3, 150.2, 142.7, 131.3, 125.8, 121.0, 120.8, 119.3,
113.8, 82.5, 70.5, 67.2, 65.5, 55.6, 55.4, 28.7, 0.00 ppm. IR (CHCl3):
Experimental Section
General Methods: 1H and 13C NMR spectra were recorded with
a Bruker Avance-300, a Varian VRX-300S, or a Bruker AC-200
instrument. NMR spectra were recorded in CDCl3 solutions, unless
otherwise stated. Chemical shifts are given in ppm relative to TMS
(1H NMR, 0.0 ppm), or CDCl3 (13C NMR, 76.9 ppm). Low and
high resolution mass spectra were recorded with a HP5989A spec-
trometer by using the electronic impact (EI) or electrospray modes
(ES), unless otherwise stated. Specific rotations [α]D are given in
10–1 °cm2 g–1 at 20 °C, and the concentration (c) is expressed in
g100 mL–1. All commercially available compounds were used with-
out further purification.
ν = 1741 cm–1. MS (ES): m/z (%) = 431 (100) [M + H]+, 430 (11)
˜
[M]+. C21H26N2O4SSi (430.6): calcd. C 58.58, H 6.09, N 6.51;
found C 58.47, H 6.06, N 6.55. The more polar fraction contained
spiranic α-alkoxy-γ-keto carboxamide (–)-9c (47 mg, 52%) as a pale
yellow oil. [α]D = –44.0 (c = 0.3, CHCl3). 1H NMR (300 MHz,
CDCl3, 25 °C): δ = 8.48 (br. s, 1 H), 7.98 (d, J = 3.0 Hz, 1 H), 7.66
(d, J = 3.0 Hz, 1 H), 7.50 and 6.87 (d, J = 9.0 Hz, each 2 H), 5.85
(m, 2 H), 4.37 and 4.32 (d, J = 16.0 Hz, each 1 H), 3.79 (s, 3 H),
4.16 and 3.65 (d, J = 17.0 Hz, each 1 H), 2.50 (m, 2 H) ppm. 13C
NMR (75 MHz, CDCl3): δ = 189.9, 171.4, 167.0, 156.3, 144.7,
130.7, 126.7, 124.6, 122.4, 121.5, 114.1, 75.3, 62.2, 55.5, 40.2,
General Procedure for the Synthesis of Spiranic and Tertiary α-Alk-
oxy-γ-keto Acid Derivatives 9: A solution of TMST (94 mg,
0.60 mmol) in anhydrous dichloromethane (0.35 mL) was added
dropwise to a solution cooled to 0 °C of the corresponding 4-
oxoazetidine-2-carbaldehyde 2 (0.50 mmol) in the same solvent
(0.5 mL). The reaction was placed in a 0 °C freezer overnight. The
mixture was extracted with EtOAc, washed with water, dried with
MgSO4, filtered, and concentrated under reduced pressure.
Chromatography of the residue (ethyl acetate/hexanes) gave a more
polar fraction containing the corresponding α-alkoxy-γ-keto amide
9, and a less polar compound, containing the free carbinol or its
trimethylsilyl ether 10. Spectroscopic and analytical data for some
representative forms of 9 and 10 follow.[11]
32.5 ppm. IR (CHCl ): ν = 1740, 1724 cm–1. MS (ES): m/z (%) =
˜
3
359 (100) [M + H]+, 358 (23) [M]+. C18H18N2O4S (358.4): calcd. C
60.32, H 5.06, N 7.82; found C 60.44, H 5.03, N 7.78.
Spiranic α-Alkoxy-γ-keto Carboxamide (–)-9d and β-Lactam (+)-
10d: From 4-oxoazetidine-2-carbaldehyde (+)-2d (60 mg,
0.19 mmol). Chromatography (EtOAc/hexanes, 1:3) gave two frac-
tions. The less polar fraction contained β-lactam (+)-10d (15 mg,
1
20%) as a colorless oil. [α]D = +28.0 (c = 0.8, CHCl3). H NMR
(300 MHz, CDCl3, 25 °C): δ = 7.40 (d, J = 8.5 Hz, 1 H), 7.63 and
7.11 (d, J = 3.4 Hz, each 1 H), 6.37 (dd, J = 8.5, 2.4 Hz, 1 H), 6.15
(d, J = 2.4 Hz, 1 H), 5.83 (q, J = 1.8 Hz, 1 H), 5.39 and 5.02 (d, J
= 1.5 Hz, each 1 H), 4.84 (m, 2 H), 3.74 and 3.60 (s, each 3 H),
1.90 (q, J = 1.9 Hz, 3 H) ppm. 13C NMR (75 MHz, CDCl3): δ =
171.2, 167.3, 159.3, 153.3, 139.1, 132.4, 126.9, 124.6, 120.9, 117.1,
103.9, 101.9, 98.6, 75.4, 70.3, 67.0, 55.5, 55.4, 10.9 ppm. IR
Tertiary α-Alkoxy-γ-keto Carboxamide (–)-9b and β-Lactam (+)-
10b: From 4-oxoazetidine-2-carbaldehyde (+)-2b (63 mg,
0.18 mmol). Chromatography (EtOAc/hexanes, 1:3) gave two frac-
tions. The less polar fraction contained β-lactam (+)-10b (20 mg,
(CHCl ): ν = 3342, 1742 cm–1. MS (ES): m/z (%) = 389 (100) [M
˜
3
Eur. J. Org. Chem. 2007, 3707–3710
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3709